Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response
Abstract Fermented butyrate exhibits an anti-inflammatory response to maintain immune homeostasis within the gut. However, the effect and underlying mechanism of butyrate on myasthenia gravis (MG) remain unclear. The changes in the gut microbiota and fecal contents of SCFAs in MG patients were exami...
Saved in:
Main Authors: | Jing Sun (Author), Juanjuan Chen (Author), Qinfang Xie (Author), Mengjiao Sun (Author), Wenjing Zhang (Author), Hongxia Wang (Author), Ning Liu (Author), Qi Wang (Author), Manxia Wang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Sodium butyrate alleviates R97-116 peptide-induced myasthenia gravis in mice by improving the gut microbiota and modulating immune response
by: Jing Sun, et al.
Published: (2024) -
The Role of Human Microbiota in Myasthenia Gravis: A Narrative Review
by: Giuseppe Schirò, et al.
Published: (2023) -
Astragaloside IV ameliorates experimental autoimmune myasthenia gravis by regulating CD4 + T cells and altering gut microbiota
by: Senhui Weng, et al.
Published: (2023) -
Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
by: Courtney Townsel, et al.
Published: (2016) -
Physiotherapy in myasthenia gravis
by: Klaudia Kwiatkowska, et al.
Published: (2018)